Coronary artery calcium score for cardiovascular risk assessment in inflammatory bowel disease – Data from first pilot prospective study
- 2 August 2024
- journal article
- letter
- Published by Elsevier in Digestive and Liver Disease
- Vol. 56 (11) , 1965-1967
Abstract
No abstract availableKeywords
Funding Information
- Takeda Pharmaceuticals U.S.A.
- Medical College of Wisconsin
This publication has 8 references indexed in Scilit:
- Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensusDigestive and Liver Disease, 2024
- Coronary artery calcium scoring for cardiovascular risk assessment in patients with inflammatory bowel diseaseAmerican Heart Journal, 2023
- Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2020
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive SummaryJACC, 2019
- Coronary artery calcium scoring for individualized cardiovascular risk estimation in important patient subpopulations after the 2019 AHA/ACC primary prevention guidelinesProgress in Cardiovascular Diseases, 2019
- High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term OutcomesJournal of the American Heart Association, 2018
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 updateAnnals of the Rheumatic Diseases, 2017
- 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk FactorsJACC, 2015